Reshma Kewalramani, EVP and CMO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,093 shares at $240.75 ($1.3M) on 2020-02-06, disclosed to the SEC on 2020-02-07.
Open-market sale of $1.3M VRTX by EVP and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $155.57 | 510 | $79K | 5.9% |
| 2 | $187.53 | 1,564 | $293K | 22.0% |
| 3 | $238.76 | 1,251 | $299K | 22.4% |
| 4 | $238.76 | 1,251 | $299K | 22.4% |
| 5 | $239.69 | 423 | $101K | 7.6% |
| 6 | $239.69 | 423 |
| $101K |
| 7.6% |
| 7 | $240.75 | 271 | $65K | 4.9% |
| 8 | $240.75 | 271 | $65K | 4.9% |
| 9 | $242.47 | 129 | $31K | 2.3% |
| Total | $219.03 avg | 6,093 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |